Globus Medical, Inc.
GMED
Classifica tra le azioni
#1980
Globus Medical, Inc. is a global medical technology company dedicated to... Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Prezzo delle azioni
$79.05
Capitalizzazione di mercato
$10.61B
Variazione (1 giorno)
4.29%
Variazione (1 anno)
28.37%
Paese
US
Scambia Globus Medical, Inc. (GMED)
Categoria
Healthcare
Rapporto P/B per Globus Medical, Inc. (GMED)
Rapporto P/B al October 2026 TTM: 2.17
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Globus Medical, Inc., il rapporto P/B attuale (TTM) è 2.17. Alla fine del 2023, era pari a 1.51.
Storico del rapporto P/B per Globus Medical, Inc. da 2009 a 2026
Rapporto P/B alla fine di ogni anno
| Anno | Rapporto P/B | Cambia |
|---|---|---|
| 2026 (TTM) | 2.17 | -19.47% |
| 2024 | 2.69 | 78.27% |
| 2023 | 1.51 | -62.70% |
| 2022 | 4.04 | -3.24% |
| 2021 | 4.18 | -2.15% |
| 2020 | 4.27 | 2.54% |
| 2019 | 4.16 | 16.49% |
| 2018 | 3.57 | -12.57% |
| 2017 | 4.09 | 43.32% |
| 2016 | 2.85 | -22.85% |
| 2015 | 3.70 | -3.38% |
| 2014 | 3.83 | -3.34% |
| 2013 | 3.96 | 62.75% |
| 2012 | 2.43 | -29.99% |
| 2011 | 3.47 | -19.22% |
| 2010 | 4.30 | 0.00% |
| 2009 | 0.00 | 0.00% |
Rapporto P/B per aziende simili o concorrenti
| Azienda | Rapporto P/B | Differenza del rapporto P/B | Il paese |
|---|---|---|---|
| 3.5116 | 62.11% |
US
|
|
| 2.0146 | -7.00% |
IE
|
|
| 4.5025 | 107.85% |
US
|
|
| 2.5486 | 17.65% |
US
|
|
| - | - |
DE
|
